Business · 19/01/2018
FDA Releases Draft Guidance on Labeling Regulations for Human Prescription Drugs and Biological Products
The FDA is releasing a draft guidance to standardize the labeling of human prescription drugs and biological products, requiring a clear product title and initial U.S. approval year in the Highlights of Prescribing Information.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →